| Předmět: |
|
| Zdroj: |
Women's Health Weekly; 11/23/2023, p765-765, 1p |
| Abstrakt: |
A recent study conducted by researchers at Eastern Virginia Medical School challenges the current recommendations for low-dose aspirin therapy in the prevention of preeclampsia. The American College of Obstetricians and Gynecologists recommends 81 mg of aspirin daily for women at risk of preeclampsia between 12 and 28 weeks' gestation, while the World Health Organization suggests initiating 75 mg of aspirin before 20 weeks of gestation for high-risk women. However, the study suggests that doses of >100 mg of aspirin daily initiated before 16 weeks' gestation may be more effective at reducing the risk of preeclampsia. The researchers call for further randomized control trials to assess the safety and efficacy of different aspirin dosages. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
